|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
13 January 2015 |
|
Main ID: |
ISRCTN87769578 |
|
Date of registration:
|
12/09/2003 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Ultrasound therapy for plantar fasciitis. A double blind randomised placebo controlled trial
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
12/10/2000 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN87769578 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial (Not Specified)
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
Cathy
Speed |
|
Address:
|
Box No 204
Department of Rheumatology
Addenbrooke's NHS Trust
Hills Road
CB2 2QQ
Cambridge
United Kingdom |
|
Telephone:
|
+44 (0)1223 586518 |
|
Email:
|
cathy.speed@btinternet.com |
|
Affiliation:
|
|
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 200 (PROJ)
Exclusion criteria: Does not meet inclusion criteria
Age minimum:
Age maximum:
Gender:
Not Specified
|
|
Health Condition(s) or Problem(s) studied
|
Musculoskeletal Diseases: Plantar fasciitis
Musculoskeletal Diseases
Fibroblastic disorders
|
|
Intervention(s)
|
|
To evaluate the effects of ultrasound in the treatment of plantar fasciitis. Adult subjects with plantar fasciitis will be randomised to receive either ultrasound (US) or sham (S) therapy. In the US group pulsed ultrasound will be delivered at a standardised dosage, initially five times weekly for 3 weeks, then three times weekly for 3 weeks. A single machine will be used and calibrated twice daily. The patient, assessor and treating clinician will all be blinded. Outcome measures will be recorded at 6 weeks and at 4 months from baseline. These will include an ankle and foot score and pain (primary measures), isokinetic strength of ankle plantar flexion and dorsifexion, flexibility, inflammation (thermographic score), quality of life and general health status, a summary item of status of the injury and a follow up transition item.
|
|
Primary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary ID(s)
|
|
N0544093542
|
|
Source(s) of Monetary Support
|
|
Cambridge Consortium - Addenbrooke's (UK)
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|